$29.19
2.28%
Nasdaq, Sep 12, 10:00 pm CET
ISIN
US81684M1045
Symbol
SMLR

Semler Scientific Stock price

$29.19
-5.35 15.49% 1M
-4.41 13.13% 6M
-24.81 45.94% YTD
+4.60 18.71% 1Y
-16.05 35.48% 3Y
-24.81 45.94% 5Y
+26.54 1,001.51% 10Y
+22.20 317.60% 20Y
Nasdaq, Closing price Fri, Sep 12 2025
+0.65 2.28%
ISIN
US81684M1045
Symbol
SMLR

Key metrics

Basic
Market capitalization
$432.2m
Enterprise Value
$514.7m
Net debt
$82.5m
Cash
$13.8m
Shares outstanding
13.7m
Valuation (TTM | estimate)
P/E
10.7 | negative
P/S
10.1 | 12.8
EV/Sales
12.0 | 15.2
EV/FCF
42.3
P/B
1.1
Financial Health
Equity Ratio
96.2%
Return on Equity
17.7%
ROCE
1.1%
ROIC
0.9%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$43.0m | $33.8m
EBITDA
$5.7m | $-41.8m
EBIT
$5.2m | $-35.1m
Net Income
$37.1m | $-47.1m
Free Cash Flow
$12.2m
Growth (TTM | estimate)
Revenue
-30.4% | -40.0%
EBITDA
-73.5% | -294.3%
EBIT
-74.9% | -267.8%
Net Income
134.2% | -215.2%
Free Cash Flow
-38.7%
Margin (TTM | estimate)
Gross
90.9%
EBITDA
13.2% | -123.7%
EBIT
12.2%
Net
86.2% | -139.5%
Free Cash Flow
28.3%
More
EPS
$2.7
FCF per Share
$0.9
Short interest
19.2%
Employees
79
Rev per Employee
$710.0k
Show more

Is Semler Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Semler Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Semler Scientific forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Semler Scientific forecast:

Buy
89%
Hold
11%

Financial data from Semler Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
43 43
30% 30%
100%
- Direct Costs 3.91 3.91
44% 44%
9%
39 39
29% 29%
91%
- Selling and Administrative Expenses 29 29
2% 2%
68%
- Research and Development Expense 4.77 4.77
4% 4%
11%
5.69 5.69
74% 74%
13%
- Depreciation and Amortization 0.46 0.46
31% 31%
1%
EBIT (Operating Income) EBIT 5.23 5.23
75% 75%
12%
Net Profit 37 37
134% 134%
86%

In millions USD.

Don't miss a Thing! We will send you all news about Semler Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Semler Scientific Stock News

Neutral
PRNewsWire
about 12 hours ago
NEW YORK , Sept. 14, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the "Class Period"), of the important October 28, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Neutral
PRNewsWire
one day ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Semler Scientific To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Semler Scientific between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directl...
Neutral
PRNewsWire
3 days ago
LOS ANGELES , Sept. 11, 2025 /PRNewswire/ -- The Law Offices of Frank R.
More Semler Scientific News

Company Profile

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluate its customers patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.

Head office United States
CEO Douglas Murphy-Chutorian
Employees 79
Founded 2007
Website www.semlerscientific.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today